C-X-C motif chemokine receptor 4 enhances the role of Toll-like receptor 2 in the formation of atherosclerotic lesions promoted by Chlamydia pneumoniae infection
CSTR:
Author:
Affiliation:

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China0

Clc Number:

R363;R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [25]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Aim To explore the role of C-X-C motif chemokine receptor 4 (CXCR4) in the formation of atherosclerosis (As) induced by Chlamydia pneumoniae (C.pn) infection. Methods The As model in mice of ApoE-/-, ApoE-/-+TLR2-/- and ApoE-/-+Toll-like receptor 2 (TLR2)-/-+AMD3100 induced by C.pn infection was established on the basis of high fat diet. C.pn IgG and IgM antibody levels were detected by ELISA, and C.pn specific DNA was detected by PCR. Lipid deposition and As lesion area in aorta and aortic root were observed by oil red O and HE staining. Serum levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDLC) and high density lipoprotein cholesterol (HDLC) were analyzed by colorimetry, and ELISA was used to measure the contents of serum interleukin-1β (IL-1β) and interleukin-6 (IL-6). Results The ApoE-/- mice model of C.pn infection was established successfully. Compared with the control group, lipid deposition in aorta and aortic root of ApoE-/- mice increased by 89.08% and 71.83%, and As lesion area increased by 34.12% after C.pn infection (all P<0.05). Compared with the C.pn infection group, lipid deposition in aorta and aortic root reduced by 46.16% and 75.73%, and the lesion area of As decreased by 63.37% in the TLR2-/-+C.pn infection group (all P<0.05). Compared with the TLR2-/-+C.pn infection group, lipid deposition in aorta and aortic root decreased by 26.19% and 56.94%, and the lesion area of As decreased by 22.24 % in the TLR2-/-+AMD3100+C.pn infection group (all P<0.05). Compared with the control group, serum levels of TC, TG and LDLC increased by 0.62 times, 1.43 times and 1.34 times after C.pn infection, respectively, while serum contents of IL-1β and IL-6 increased by 4.10 times and 6.00 times, respectively (all P<0.05). Compared with the C.pn infection group, serum levels of TC, TG and LDLC in the TLR2-/-+C.pn infection group decreased by 56.96%, 50.41% and 66.64%, and serum contents of IL-1β and IL-6 also decreased by 66.72% and 69.54% respectively (all P<0.05). Compared with the TLR2-/-+C.pn infection group, serum levels of TC, TG and LDLC in the TLR2-/-+AMD3100+C.pn infection group decreased by 52.18%, 58.56% and 60.61%, and serum contents of IL-1β and IL-6 and reduced by 28.84% and 43.18%, respectively (all P<0.05). Conclusion CXCR4 enhances the roles of TLR2 in increasing the serum lipid levels and the contents of inflammatory factors, and then participates in the formation of As lesions induced by C.pn infection.

    Reference
    [1] ROTH G A, MENSAH G A, FUSTER V.The global burden of cardiovascular diseases and risks:a compass for global action.J Am Coll Cardiol, 0,6(25):2980-2981.
    [2] RIDKER P M, BHATT D L, PRADHAN A D, et al.Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy:a collaborative analysis of three randomised trials.Lancet, 3,1(10384):1293-1301.
    [3] ZHAO X, MIAO G L, ZHANG L J, et al.Chlamydia pneumoniae infection induces vascular smooth muscle cell migration and atherosclerosis through mitochondrial reactive oxygen species-mediated JunB-Fra-1 activation.Front Cell Dev Biol, 2,0:879023.
    [4] CHEN S, SHIMADA K, CROTHER T R, et al.Chlamydia and lipids engage a common signaling pathway that promotes atherogenesis.J Am Coll Cardiol, 8,1(14):1553-1570.
    [5] GAYDOS C A, SUMMERSGILL J T, SAHNEY N N, et al.Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells.Infect Immun, 6,4(5):1614-1620.
    [6] RUPP J, KOCH M, VAN ZANDBERGEN G, et al.Transmission of Chlamydia pneumoniae infection from blood monocytes to vascular cells in a novel transendothelial migration model.FEMS Microbiol Lett, 5,2(2):203-208.
    [7] DUAN T H, DU Y, XING C S, et al.Toll-like receptor signaling and its role in cell-mediated immunity.Front Immunol, 2,3:812774.
    [8] 王克华, 王金, 王磊, 等.circ-SKA3通过miR-1303调控TLR4轴在动脉粥样硬化中的作用.中国动脉硬化杂志, 3,1(11):1-23.WANG K H, WANG J, WANG L, et al.circ-SKA3 regulates the role of TLR4 axis in atherosclerosis through miR-1303.Chin J Arterioscler, 3,1(11):1-23.
    [9] WANG Y G, CHEN L, TIAN Z, et al.CRISPR-Cas9 mediated gene knockout in human coronary artery endothelial cells reveals a pro-inflammatory role of TLR2.Cell Biol Int, 8,2(2):187-193.
    [10] MARANGONI A, FIORINO E, GILARDI F, et al.Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice.Atherosclerosis, 5,1(2):471-479.
    [11] ZHAO G J, MO Z C, TANG S L, et al.Chlamydia pneumoniae negatively regulates ABCA1 expression via TLR2-Nuclear factor-kappa B and miR-33 pathways in THP-1 macrophage-derived foam cells.Atherosclerosis, 4,5(2):519-525.
    [12] ROUSSOS E T, CONDEELIS J S, PATSIALOU A.Chemotaxis in cancer.Nat Rev Cancer, 1,1(8):573-587.
    [13] MIAO G L, ZHAO X, WANG B B, et al.TLR2/CXCR4 coassociation facilitates Chlamydia pneumoniae infection-induced atherosclerosis.Am J Physiol Heart Circ Physiol, 0,8(6):H1420-H1435.
    [14] WANG B B, ZHANG L J, ZHANG T T, et al.Chlamydia pneumoniae infection promotes vascular smooth muscle cell migration through a Toll-like receptor 2-related signaling pathway.Infect Immun, 3,1(12):4583-4591.
    [15] MALEKMOHAMMAD K, BEZSONOV E E, RAFIEIAN-KOPAEI M.Role of lipid accumulation and inflammation in atherosclerosis:focus on molecular and cellular mechanisms.Front Cardiovasc Med, 1,8:707529.
    [16] LIBBY P, BURING J E, BADIMON L, et al.Atherosclerosis.Nat Rev Dis Primers, 9,5(1):56.
    [17] HAJISHENGALLIS G, WANG M, LIANG S, et al.Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function.Proc Natl Acad Sci U S A, 8,5(36):13532-13537.
    [18] RIDKER P M.Anticytokine agents:targeting interleukin signaling pathways for the treatment of atherothrombosis.Circ Res, 9,4(3):437-450.
    [19] TUMURKHUU G, DAGVADORJ J, PORRITT R A, et al.Chlamydia pneumoniae hijacks a host autoregulatory IL-1β loop to drive foam cell formation and accelerate atherosclerosis.Cell Metab, 8,8(3):432-448.
    [20] NAIKI Y, SORRENTINO R, WONG M H, et al.TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.J Immunol, 8,1(10):7176-7185.
    [21] LIU Z Y, SONG Z W, GUO S W, et al.CXCL12/CXCR4 signaling contributes to neuropathic pain via central sensitization mechanisms in a rat spinal nerve ligation model.CNS Neurosci Ther, 9,5(9):922-936.
    [22] LI Y, ZHANG L, REN P, et al.Qing-Xue-Xiao-Zhi formula attenuates atherosclerosis by inhibiting macrophage lipid accumulation and inflammatory response via TLR4/MyD88/NF-κB pathway regulation.Phytomedicine, 1,3:153812.
    [23] TUN J, BCK M, BADIMN L, et al.Interplay between hypercholesterolaemia and inflammation in atherosclerosis:translating experimental targets into clinical practice.Eur J Prev Cardiol, 8,5(9):948-955.
    [24] RIDKER P M.From C-reactive protein to interleukin-6 to interleukin-1:moving upstream to identify novel targets for atheroprotection.Circ Res, 6,8(1):145-156.
    [25] WANG J Z, TANNOUS B A, POZNANSKY M C, et al.CXCR4 antagonist AMD3100 (plerixafor):from an impurity to a therapeutic agent.Pharmacol Res, 0,9:105010.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

ZHANG Qi, ZHANG Lijun, ZHANG Yuke, LI Yi, ZHAO Xi, MIAO Guolin, WANG Beibei, ZHANG Lijun. C-X-C motif chemokine receptor 4 enhances the role of Toll-like receptor 2 in the formation of atherosclerotic lesions promoted by Chlamydia pneumoniae infection[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2024,32(2):102-108.

Copy
Share
Article Metrics
  • Abstract:197
  • PDF: 834
  • HTML: 0
  • Cited by: 0
History
  • Received:October 12,2023
  • Revised:December 15,2023
  • Online: February 22,2024
Article QR Code